semaglutide eu Weight-loss anarchy in the EU Launches Investigation Into Ozempic

Together, obesity and type 2 diabetes constitute one of the more preventable causes of premature death and the identification of novel, safe and effective anti-obesity drugs is of utmost importance

Treatment benefits fade rapidly, with only 6.2% of patients maintaining effects at 6 months post-treatment

For perspective, the peptide safety guide covers general principles for handling dosing errors

Providing care beyond body size Patients on GLP-1s may have different vulnerabilities, and clinicians have different philosophies about how safe the drugs areand who should receive them

Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder